Lobbying Filing Details

Total Spending

$0

Activities

3

Lobbyists

2

Gov't Entities

0

Filing Information
Filing UUID:
09f32e91-3f4f-4b02-94f3-30f17203afc8
Type:
RA - Registration - Amendment
Period:
2002 - Mid-Year (Jan 1 - Jun 30)
Date Posted:
August 06, 2019 at 4:00 AM
Income:
$0
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Robert Tyrer, Co-Present
Registrant
THE COHEN GROUP

International strategic business consulting

Washington, District of Columbia
Client
GENESOFT, INC.

The developing a new class of genomic medicines for treatment of chronic & acute diseases

California, United States of America
Lobbying Activities (3)
Activity 1
Budget/Appropriations

Increasing awareness of and funding for research and development of a new class of medicines for treatment of biowarfare pathogens

Lobbyists (2)
  • PAUL GEBHARD
  • MARA RUDMAN
Activity 2
Defense

Increasing awareness of and funding for research and development of a new class of medicines for treatment of biowarfare pathogens

Lobbyists (2)
  • PAUL GEBHARD
  • MARA RUDMAN
Activity 3
Medical/Disease Research/Clinical Labs

Increasing awareness of and funding for research and development of a new class of medicines for treatment of biowarfare pathogens

Lobbyists (2)
  • PAUL GEBHARD
  • MARA RUDMAN

Source: LDA.gov, data retrieved November 4, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.